Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
Clinical trial NCT03069989 · TERMINATED
Trial details
- NCT number
- NCT03069989
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2018-07-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.